Walleye Capital LLC

Position in OGN — Organon & Co.

CIK 1758720 NEW YORK, NY

Back to OGN Full portfolio

Position in OGN

as of Jun 30, 2026 · filed Aug 3, 2026 Compact

Position Value

-$2,354,818 QoQ

Shares Held

-100.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2022

16 quarters on record

Common Shares in OGN Over Time

Shares Held

Position Value (USD)

Derivatives in OGN

reported options exposure · as of Jun 30, 2026

CallValue

$1,123,820

CallShares

83,000

PutValue

$161,126

PutShares

11,900

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Walleye Capital LLC holds $213,456,876 across 14 Drug Manufacturers - General names.

#	Ticker	Company	Shares	Value (USD)
1	AMGN	Amgen Inc	240,318	$87,023,954
2	PFE	Pfizer Inc	2,417,136	$58,204,634
3	LLY	ELI LILLY & Co	28,457	$34,132,182
4	GSK	GSK plc	402,472	$21,097,582
5	NVO	Novo Nordisk A S	194,159	$9,307,982
6	SNY	Sanofi	33,051	$1,409,955
7	BMY	Bristol Myers Squibb Co	18,084	$1,042,000
8	JNJ	Johnson & Johnson	1,394	$354,034

All Filings in OGN

Export CSV

42 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,123,820	83,000	-57.5%	Call	Sole	2026-08-03
2026-06-30	$161,126	11,900	-79.2%	Put	Sole	2026-08-03
2026-03-31	$1,171,045	195,500	-46.4%	Call	Sole	2026-05-13
2026-03-31	$2,354,818	393,125	-73.5%	Shares	Sole	2026-05-13
2026-03-31	$342,029	57,100	-38.6%	Put	Sole	2026-05-13
2025-12-31	$10,650,167	1,485,379	+2730.6%	Shares	Sole	2026-02-13
2025-12-31	$666,810	93,000	+61.7%	Put	Sole	2026-02-13
2025-12-31	$2,613,465	364,500	+139.3%	Call	Sole	2026-02-13
2025-09-30	$560,443	52,476	+126.9%	Shares	Sole	2025-11-14
2025-09-30	$1,626,564	152,300	-24.9%	Call	Sole	2025-11-14
2025-09-30	$614,100	57,500	+34.7%	Put	Sole	2025-11-14
2025-06-30	$1,964,072	202,900	+66.7%	Call	Sole	2025-08-13
2025-06-30	$413,336	42,700	-64.4%	Put	Sole	2025-08-13
2025-03-31	$344,361	23,127	-69.3%	Shares	Sole	2025-05-14
2025-03-31	$1,812,113	121,700	+120.9%	Call	Sole	2025-05-14
2025-03-31	$1,785,311	119,900	+253.7%	Put	Sole	2025-05-14
2024-12-31	$822,092	55,100	-25.0%	Call	Sole	2025-02-13
2024-12-31	$1,125,505	75,436	+3.9%	Shares	Sole	2025-02-13
2024-12-31	$505,788	33,900	-77.9%	Put	Sole	2025-02-13
2024-09-30	$1,406,055	73,500	-0.1%	Call	Sole	2024-11-14
2024-09-30	$2,934,542	153,400	-20.9%	Put	Sole	2024-11-14
2024-09-30	$1,388,971	72,607	+8.5%	Shares	Sole	2024-11-14
2024-06-30	$4,015,800	194,000	-12.3%	Put	Sole	2024-08-14
2024-06-30	$1,384,685	66,893	-7.8%	Shares	Sole	2024-08-14
2024-06-30	$1,523,520	73,600	-28.3%	Call	Sole	2024-08-14
2024-03-31	$4,156,680	221,100	+1069.8%	Put	Sole	2024-05-15
2024-03-31	$1,930,760	102,700	+14.6%	Call	Sole	2024-05-15
2023-12-31	$1,046,185	72,551	+45.7%	Shares	Sole	2024-02-14
2023-12-31	$1,292,032	89,600	+470.7%	Call	Sole	2024-02-14
2023-12-31	$272,538	18,900	+75.0%	Put	Sole	2024-02-14
2023-09-30	$187,488	10,800	+11.3%	Put	Sole	2023-11-21
2023-09-30	$272,552	15,700	-18.2%	Call	Sole	2023-11-21
2023-09-30	$864,666	49,808	+28.6%	Shares	Sole	2023-11-21
2023-06-30	$201,857	9,700	+31.1%	Put	Sole	2023-08-14
2023-06-30	$399,552	19,200	+76.1%	Call	Sole	2023-08-14
2023-06-30	$806,179	38,740	+64.8%	Shares	Sole	2023-08-14
2023-03-31	$174,048	7,400	+25.4%	Put	Sole	2023-05-15
2023-03-31	$256,368	10,900	+5.8%	Call	Sole	2023-05-15
2023-03-31	$552,955	23,510	—	Shares	Sole	2023-05-15
2022-12-31	$287,679	10,300	-10.4%	Call	Sole	2023-02-14
2022-12-31	$164,787	5,900	—	Put	Sole	2023-02-14
2022-09-30	$269,100	11,500	—	Call	Sole	2022-11-14
No filing history on record for this holder in this stock.